Orexin-1 Receptor Neurons

Orexin-1 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Orexin-1 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Orexin 1 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Orexin-1 receptor neurons (HCRTR1-expressing neurons) are a specialized population of neurons that express the orexin-1 receptor (HCRTR1), a G protein-coupled receptor (GPCR) that binds orexin-A and orexin-B neuropeptides. These neurons form a crucial component of the orexin system, which regulates arousal, wakefulness, reward processing, energy homeostasis, and cognitive function. The orexin system, also known as the hypocretin system, was discovered independently by two research groups in 1998 and has since become a major focus of neuroscience research[@orexins1998][@hypocretins1998].

Orexin-1 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Orexin-1 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Orexin 1 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Orexin-1 receptor neurons (HCRTR1-expressing neurons) are a specialized population of neurons that express the orexin-1 receptor (HCRTR1), a G protein-coupled receptor (GPCR) that binds orexin-A and orexin-B neuropeptides. These neurons form a crucial component of the orexin system, which regulates arousal, wakefulness, reward processing, energy homeostasis, and cognitive function. The orexin system, also known as the hypocretin system, was discovered independently by two research groups in 1998 and has since become a major focus of neuroscience research[@orexins1998][@hypocretins1998].

The HCRTR1 receptor has a high affinity for orexin-A and a lower affinity for orexin-B, while the related HCRTR2 (orexin-2 receptor) binds both neuropeptides with similar affinity. The distribution of HCRTR1 in the brain is widespread but concentrated in regions associated with arousal, motivation, and autonomic control[@distribution2001].

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: hypocretin-secreting neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Biology

Orexin Peptides

The orexin system consists of two neuropeptides and two receptors:

• Orexin-A (hypocretin-1): A 33-amino acid peptide with two intramolecular disulfide bonds
• Orexin-B (hypocretin-2): A 28-amino acid linear peptide

HCRTR1 Receptor Structure

The human HCRTR1 gene (Hydroxycarboxylic Acid Receptor 1; previously named Orexin Receptor 1) is located on chromosome 1p33 and encodes a 425-amino acid GPCR with seven transmembrane domains. Key structural features include:

• Extracellular N-terminus: Contains glycosylation sites important for ligand binding
• Transmembrane domains: Seven hydrophobic helices that form the receptor core
• Intracellular C-terminus: Couples to G proteins and contains phosphorylation sites for receptor regulation

Signaling Pathways

Upon orexin binding, HCRTR1 activates multiple intracellular signaling pathways:

Location

Primary Locations

HCRTR1-expressing neurons are found in several key brain regions:

Projections

Orexin neurons in the lateral hypothalamus project to:

• Cortex (prefrontal, parietal, occipital)
• Thalamus (intralaminar, mediodorsal nuclei)
• Brainstem (locus coeruleus, dorsal raphe, pedunculopontine nucleus)
• Hypothalamus (tuberomammillary nucleus, suprachiasmatic nucleus)
• Spinal cord (sympathetic preganglionic neurons)

Function

Arousal and Wakefulness

The orexin system is the primary wake-promoting neuropeptide system in the brain:

• Wake maintenance: Orexin neurons fire continuously during wakefulness and cease firing during sleep
• State transitions: Orexin signaling facilitates transitions from sleep to wakefulness
• Arousal threshold: HCRTR1 activation raises arousal threshold, maintaining sustained attention

Reward and Motivation

HCRTR1 in the mesolimbic dopamine system regulates reward processing:

• Reward seeking: Orexin acts on VTA and NAc neurons to promote reward-directed behavior
• Motivation: HCRTR1 signaling enhances motivational drive and food-seeking behavior
• Addiction: The orexin system is implicated in drug addiction and relapse

Energy Homeostasis

Orexin neurons integrate metabolic signals to regulate energy balance:

• Food intake: Orexin promotes feeding behavior through HCRTR1 in hypothalamic and limbic regions
• Energy expenditure: Orexin increases locomotor activity and thermogenesis
• Glucose regulation: Orexin modulates glucose metabolism and insulin sensitivity

Cognitive Function

HCRTR1 signaling affects multiple cognitive domains:

• Attention: Prefrontal cortical HCRTR1 enhances attention and working memory
• Learning: Hippocampal orexin signaling modulates synaptic plasticity and memory consolidation
• Decision making: Orbitofrontal cortex HCRTR1 influences risk-reward decision making

Role in Disease

Narcolepsy

Narcolepsy type 1 is caused by loss of orexin-producing neurons (90% loss) or HCRTR2 mutations. While HCRTR1 mutations are less common, they contribute to narcolepsy susceptibility:

• Autoimmune hypothesis: Autoimmune destruction of orexin neurons in narcolepsy with cataplexy
• HCRTR1 antagonists: Dual orexin receptor antagonists (DORAs) like suvorexant cause sleepiness
• Therapeutic targeting: HCRTR1 agonists are being developed for narcolepsy treatment

Alzheimer's Disease

The orexin system is significantly affected in Alzheimer's disease:

• Orexin neuron loss: Reduced orexin neuron numbers in AD patients
• Sleep disturbances: Elevated orexin levels in CSF of AD patients with sleep disruptions
• Amyloid relationship: Orexin interacts with amyloid-beta pathology
• Therapeutic implications: HCRTR1 modulation may improve sleep and potentially modify disease progression

Parkinson's Disease

Orexin dysfunction contributes to Parkinson's disease symptoms:

• Sleep disorders: REM sleep behavior disorder often precedes PD motor symptoms
• Orexin deficiency: Reduced orexin levels in PD patients correlate with disease severity
• Cognition: Orexin deficits may contribute to PD dementia
• Therapeutic potential: HCRTR1 agonists may improve alertness in PD patients

Depression and Anxiety

The orexin system participates in mood regulation:

• Depression: Dysregulated orexin signaling in major depressive disorder
• Anxiety: HCRTR1 in the amygdala modulates anxiety-like behaviors
• Stress response: Orexin neurons are activated by stress and regulate stress responses
• Treatment potential: HCRTR1 antagonists have anxiolytic and antidepressant-like effects

Obesity and Metabolic Disorders

Given orexin's role in energy homeostasis:

• Food intake: HCRTR1 antagonists reduce food intake and body weight
• Metabolic syndrome: Orexin dysregulation contributes to metabolic dysfunction
• Bariatric surgery: Changes in orexin signaling may mediate surgical weight loss effects
• Therapeutic targeting: HCRTR1 antagonists are being developed for obesity treatment

Research Applications

Drug Development

HCRTR1 is a major drug target:

• Antagonists: SB-9200, GSK1059865, and other HCRTR1 antagonists for obesity and addiction
• Agonists: HCRTR1 agonists in development for narcolepsy and cognitive enhancement
• Dual antagonists: Suvorexant, lemborexant approved for insomnia

Animal Models

Key model systems include:

• Orexin/ataxin mice: Transgenic mice with orexin neuron loss (model of narcolepsy)
• HCRTR1 knockout mice: Reveal HCRTR1-specific functions
• Optogenetic models: Channelrhodopsin expression in orexin neurons for circuit mapping

Biomarkers

Orexin system markers have clinical applications:

• CSF orexin: Diagnostic marker for narcolepsy type 1 (<110 pg/mL)
• CSF HCRTR1: Potential biomarker for neurodegenerative diseases
• Sleep polysomnography: Characterizes orexin system dysfunction

See Also

• [Orexin-A
• Orexin-B
• HCRTR2
• [Lateral Hypothalamus](/cell-types/lateral-hypothalamus)
• Narcolepsy](/brain-regions/orexin-a

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [HCRTR1 Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/8941)
• [Orexin System in Sleep-Wake Regulation - Nature Reviews Neuroscience](https://www.nature.com/articles/nrn2929)
• [Narcolepsy - Sleep Research](https://www.sleepnet.com/narcolepsy)

Background

The study of Orexin 1 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

distribution2001, Distribution of orexin receptors in the rat brain (2001) (2001) [1](https://doi.org/10.1016/S0306-4522(01)
hcrtr2006, HCRTR1 signaling pathways and neuronal function (2006) (2006) [1](https://doi.org/10.1016/j.yfrne.2006.05.001)
hcrtr2021, HCRTR1 antagonists for metabolic disorders (2021) (2021) [1](https://doi.org/10.1016/j.tips.2021.01.005)
hypocretins1998, Hypocretins: waking, arousal, and incentive motivation (1998) (1998) [1](https://doi.org/10.1016/S0896-6273(00)
orexin2018, Orexin neurons and narcolepsy (2018) (2018) [1](https://doi.org/10.1016/j.tins.2018.02.006)
orexin2019, Orexin in Alzheimer's disease (2019) (2019) [1](https://doi.org/10.1016/j.neurobiolaging.2019.03.012)
orexin2020, Orexin and reward processing (2020) (2020) [1](https://doi.org/10.1016/j.neuropharm.2020.107894)
orexins1998, Orexins: neuropeptides that regulate wakefulness and energy homeostasis (1998) (1998) [1](https://doi.org/10.1016/S0092-8674(00)